Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.

Get Started

XGN

Exagen (XGN)

Exagen Inc

Date:

Regulatory News

Text Search:

Sort by:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:XGN

<< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >>

Date	Time	Source	Headline	Symbol	Company
11/30/2023	12:15AM	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NASDAQ:XGN	Exagen Inc
11/29/2023	5:11PM	Edgar (US Regulatory)	Form 424B5 - Prospectus [Rule 424(b)(5)]	NASDAQ:XGN	Exagen Inc
11/27/2023	4:05PM	Edgar (US Regulatory)	Form S-3/A - Registration statement under Securities Act of 1933: [Amend]	NASDAQ:XGN	Exagen Inc
11/20/2023	8:00AM	Edgar (US Regulatory)	Form 424B5 - Prospectus [Rule 424(b)(5)]	NASDAQ:XGN	Exagen Inc
11/17/2023	4:30PM	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:XGN	Exagen Inc
11/17/2023	4:06PM	Edgar (US Regulatory)	Form S-3 - Registration statement under Securities Act of 1933	NASDAQ:XGN	Exagen Inc
11/13/2023	5:24PM	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:XGN	Exagen Inc
11/13/2023	4:05PM	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:XGN	Exagen Inc
11/13/2023	4:05PM	GlobeNewswire Inc.	Exagen Inc. Reports Strong Third Quarter 2023 Results	NASDAQ:XGN	Exagen Inc
11/09/2023	4:05PM	GlobeNewswire Inc.	Exagen Inc. and Johns Hopkins University Announce License Agreement for Novel Patented Lupus Nephritis Biomarkers	NASDAQ:XGN	Exagen Inc
11/02/2023	4:05PM	GlobeNewswire Inc.	Exagen Inc. to Participate in the 2023 Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum	NASDAQ:XGN	Exagen Inc
10/30/2023	4:05PM	GlobeNewswire Inc.	Exagen to Announce Third Quarter 2023 Financial Results on November 13, 2023	NASDAQ:XGN	Exagen Inc
10/18/2023	4:05PM	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:XGN	Exagen Inc
10/17/2023	2:50PM	Dow Jones News	Exagen Agrees to Pay Over $650K to Resolve Kickback Allegations	NASDAQ:XGN	Exagen Inc
09/28/2023	4:05PM	GlobeNewswire Inc.	Exagen Announces Acceptance of Multiple Abstracts at ACR 2023 Annual Meeting	NASDAQ:XGN	Exagen Inc
09/12/2023	4:05PM	GlobeNewswire Inc.	Exagen Inc. to Participate in the 2023 Cantor Fitzgerald Global Healthcare Conference	NASDAQ:XGN	Exagen Inc
09/06/2023	5:05PM	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:XGN	Exagen Inc
08/07/2023	9:23AM	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:XGN	Exagen Inc
08/07/2023	8:00AM	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:XGN	Exagen Inc
08/07/2023	8:00AM	GlobeNewswire Inc.	Exagen Inc. Reports Strong Second Quarter 2023 Results	NASDAQ:XGN	Exagen Inc
07/26/2023	4:05PM	GlobeNewswire Inc.	Exagen Inc. to Participate in the Canaccord Genuity 43rd Annual Growth Conference	NASDAQ:XGN	Exagen Inc
07/25/2023	4:05PM	GlobeNewswire Inc.	Exagen to Announce Second Quarter 2023 Financial Results on August 7, 2023	NASDAQ:XGN	Exagen Inc
07/24/2023	4:05PM	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:XGN	Exagen Inc
07/24/2023	4:05PM	GlobeNewswire Inc.	Exagen Inc. Appoints Paul Kim to Board of Directors	NASDAQ:XGN	Exagen Inc
06/20/2023	4:31PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:XGN	Exagen Inc
06/14/2023	4:51PM	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:XGN	Exagen Inc
06/13/2023	4:37PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:XGN	Exagen Inc
06/13/2023	4:37PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:XGN	Exagen Inc
05/30/2023	9:00AM	GlobeNewswire Inc.	Exagen Inc. to Participate in the William Blair 43rd Annual Growth Stock Conference	NASDAQ:XGN	Exagen Inc
05/24/2023	4:16PM	Edgar (US Regulatory)	Additional Proxy Soliciting Materials (definitive) (defa14a)	NASDAQ:XGN	Exagen Inc